The Steering Committee is assembled to review abstract submissions for the annual conference. This includes reviewing abstract submissions, suggesting plenary speakers, recruiting researchers to
solicit abstracts for submission to the conference and identifying
emerging topics of interest. MSACL encourages submissions in all areas of clinical analytics.
Chair |
|
Margret Thorsteinsdottir, PhD University of Iceland Financial Disclosures (past 24 months as of Jul 11, 2024)
: none
|
Outgoing Chair |
|
Timothy Collier, PhD Quest Diagnostics Financial Disclosures (past 24 months as of Feb 12, 2024)
Stocks/Bonds: Quest
Salary: Quest
|
Steering Committee |
|
Peggi Angel, PhD MUSC Proteomics Center Financial Disclosures (past 24 months as of Feb 16, 2024)
Stocks/Bonds: GlycoPath
Board/Committee: GlycoPath, N-zyme Scientifics
|
|
Matthew Crawford Labcorp Financial Disclosures (past 24 months as of Apr 09, 2024)
Stocks/Bonds: LabCorp
Salary: LabCorp
|
|
Tim Garrett, PhD University of Florida College of Medicine Financial Disclosures (past 24 months as of Feb 13, 2024)
Grants/Research Expenses: Capitainer, Agilent Technologies, ThermoFisher
|
|
Daniel Holmes, MD, FRCPC St. Paul’s Hospital Financial Disclosures (past 24 months)
: Not reported
|
|
Ian Lewis, PhD University of Calgary Financial Disclosures (past 24 months as of Mar 15, 2023)
Grants/Research Expenses: Genome Canada, CIHR, NSERC
|
|
Renee Ruhaak, PhD LUMC Financial Disclosures (past 24 months as of Feb 13, 2024)
: none
|
Scientific Committee |
|
Nathalie Agar, PhD Brigham and Women's Hospital Financial Disclosures (past 24 months as of Jul 15, 2024)
Grants/Research Expenses: EMD Serono, Thermo Finnigan, and iTeos Therapeutics
Other Conflicts: key opinion leader for Bruker Daltonics
|
|
Michael Chen, M.D., C.M. University of British Columbia Financial Disclosures (past 24 months as of Feb 13, 2024)
: none
|
|
Shannon Haymond, PhD Northwestern University Feinberg School of Medicine Financial Disclosures (past 24 months as of Feb 13, 2024)
: none
|
|
Ron Heeren, PhD Maastricht University Financial Disclosures (past 24 months)
: Not reported
|
|
Thomas Horvath, PhD Baylor College of Medicine / Texas Children's Financial Disclosures (past 24 months as of Feb 25, 2024)
Expenses/Honoraria: Elsevier for a contracted Associate Academic Editor position with Cell Press - STAR Protocols
Board/Committee: I serve as a volunteer on the Editorial Advisory Board for Cell Press - STAR Protocols
Salary: Baylor College of Medicine
|
|
Guinevere Lageveen-Kammeijer, PhD University of Groningen Financial Disclosures (past 24 months as of Apr 03, 2024)
Grants/Research Expenses: Astelas Pharma, Roche
|
|
Ruben Y. Luo, PhD, DABCC Stanford University Financial Disclosures (past 24 months as of Mar 04, 2024)
: none
|
|
Kristina Schwamborn, MD, PhD Technical University of Munich Financial Disclosures (past 24 months as of Feb 13, 2024)
Expenses/Honoraria: Bristol Myers Squibb (BMS)
Board/Committee: BMS, Merck, MSD, Roche, Janssen-Cilag, AstraZeneca
|
|
Jody van den Ouweland, PhD Canisius-Wilhelmina Hospital Financial Disclosures (past 24 months)
: Not reported
|
|
Michael Vogeser, Prof. Dr. med. University Hospital, LMU Munich Financial Disclosures (past 24 months as of Mar 05, 2024)
Expenses/Honoraria: Roche Diagnostics
Grants/Research Expenses: Roche Diagnostics
Board/Committee: Roche Diagnostics
|
|
Dajana Vuckovic, PhD Concordia University Financial Disclosures (past 24 months)
: Not reported
|
|
Elizabeth Want, PhD Imperial College London Financial Disclosures (past 24 months as of Feb 13, 2024)
: none
|
Practical Training |
|
Deborah French, PhD, DABCC (CC, TC) (Lead) UCSF Financial Disclosures (past 24 months as of Feb 12, 2024)
Consultancy: Ark Diagnostics, Sage Biomedical
|
|
Joshua Hayden, PhD, DABCC, FACB Norton Healthcare Financial Disclosures (past 24 months as of Feb 13, 2024)
Board/Committee: BioPorto
|
|
Jacqueline Hubbard, PhD, DABCC Hubbard Lab Consulting Financial Disclosures (past 24 months as of Mar 01, 2024)
Salary: Three Rivers Diagnostics
|
|
Grace van der Gugten, B.Sc. Chemistry Alberta Precision Laboratories Financial Disclosures (past 24 months as of Feb 13, 2024)
: none
|